Russia launches new smallpox vaccine
Official approval has been granted in Russia for the registration of the drug "Nyukh-14," an anti-smallpox medication developed to treat infections caused by variola virus, monkeypox, and cowpox. This medication is based on the State Scientific Center "Vektor," and officials from the Russian Consumer Rights Protection Agency have confirmed its effectiveness in combating related viruses. This development comes amid increasing concerns over the spread of monkeypox, especially since smallpox was declared eradicated in 1980, prompting Russia to develop medicines and vaccines to address these infectious threats.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)